JP2002517393A5 - - Google Patents

Download PDF

Info

Publication number
JP2002517393A5
JP2002517393A5 JP2000552115A JP2000552115A JP2002517393A5 JP 2002517393 A5 JP2002517393 A5 JP 2002517393A5 JP 2000552115 A JP2000552115 A JP 2000552115A JP 2000552115 A JP2000552115 A JP 2000552115A JP 2002517393 A5 JP2002517393 A5 JP 2002517393A5
Authority
JP
Japan
Prior art keywords
ylmethyl
sulfonic acid
oxo
chloro
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000552115A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002517393A (ja
JP4504564B2 (ja
Filing date
Publication date
Priority claimed from US09/090,492 external-priority patent/US6602864B1/en
Application filed filed Critical
Publication of JP2002517393A publication Critical patent/JP2002517393A/ja
Publication of JP2002517393A5 publication Critical patent/JP2002517393A5/ja
Application granted granted Critical
Publication of JP4504564B2 publication Critical patent/JP4504564B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000552115A 1998-06-03 1999-06-03 スルホン酸またはスルホニルアミノｎ−（ヘテロアラルキル）−アザヘテロシクリルアミド化合物 Expired - Fee Related JP4504564B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/090,492 1998-06-03
US09/090,492 US6602864B1 (en) 1996-12-13 1998-06-03 Sulfonic acid or sulfonylamino N-(heteroaralkyl)-azaheterocyclylamide compounds
PCT/US1999/012312 WO1999062904A1 (en) 1998-06-03 1999-06-03 Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds

Publications (3)

Publication Number Publication Date
JP2002517393A JP2002517393A (ja) 2002-06-18
JP2002517393A5 true JP2002517393A5 (https=) 2006-07-13
JP4504564B2 JP4504564B2 (ja) 2010-07-14

Family

ID=22223007

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000552115A Expired - Fee Related JP4504564B2 (ja) 1998-06-03 1999-06-03 スルホン酸またはスルホニルアミノｎ−（ヘテロアラルキル）−アザヘテロシクリルアミド化合物

Country Status (12)

Country Link
US (1) US6602864B1 (https=)
EP (1) EP1086099B1 (https=)
JP (1) JP4504564B2 (https=)
KR (1) KR20010052501A (https=)
AT (1) ATE305469T1 (https=)
AU (1) AU758642B2 (https=)
BR (1) BR9910899A (https=)
CA (1) CA2333994A1 (https=)
DE (1) DE69927497T2 (https=)
ES (1) ES2246582T3 (https=)
NO (1) NO20005912L (https=)
WO (1) WO1999062904A1 (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6281227B1 (en) * 1996-12-13 2001-08-28 Aventis Pharma Deutschland Gmbh Sulfonic acid sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds
AU753675B2 (en) 1998-03-19 2002-10-24 Ajinomoto Co., Inc. Aminoisoquinoline derivatives
JP2001294572A (ja) * 2000-02-09 2001-10-23 Dai Ichi Seiyaku Co Ltd 新規スルホニル誘導体
US6506754B1 (en) * 2000-04-14 2003-01-14 Corvas International, Inc. Non-covalent thrombin inhibitors
US7229986B2 (en) 2000-05-16 2007-06-12 Takeda Pharmaceutical Company Ltd. Melanin-concentrating hormone antagonist
WO2002080853A2 (en) 2001-04-09 2002-10-17 Bristol-Myers Squibb Company Fused heterocyclic inhibitors of factor xa
GB0114005D0 (en) 2001-06-08 2001-08-01 Glaxo Group Ltd Chemical compounds
GB0114004D0 (en) 2001-06-08 2001-08-01 Glaxo Group Ltd Chemical compounds
GB0127568D0 (en) * 2001-11-16 2002-01-09 Glaxo Group Ltd Chemical compounds
AU2003302238A1 (en) 2002-12-03 2004-06-23 Axys Pharmaceuticals, Inc. 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors
GB0228552D0 (en) * 2002-12-06 2003-01-15 Glaxo Group Ltd Chemical compounds
GB0228533D0 (en) * 2002-12-06 2003-01-15 Glaxo Group Ltd Crystalline form
US7338975B2 (en) 2003-02-12 2008-03-04 Bristol-Myers Squibb Co. Lactams as modulators of chemokine receptor activity
JP2008509222A (ja) * 2004-08-09 2008-03-27 グラクソ グループ リミテッド 抗菌剤
US7511035B2 (en) 2005-01-25 2009-03-31 Glaxo Group Limited Antibacterial agents
EP1932839A4 (en) * 2005-09-06 2014-09-10 Shionogi & Co INDOLECARBOXYLATE ACID DERIVATIVE HAVING ANTAGONIST EFFECT OF THE PGD2 RECEPTOR
US20100260751A1 (en) 2007-09-28 2010-10-14 Raju T Shantha Methods and Structural Conformations of Antibody Preparations with Increased Resistance to Proteases
ES2622102T3 (es) 2009-10-29 2017-07-05 Janssen Biotech, Inc. Variantes de anticuerpo de glicosilación
EP2606893A1 (en) 2011-12-21 2013-06-26 Sanofi Sulphonylaminopyrrolidinone derivatives, their preparation and their therapeutic application

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5130323A (en) * 1988-10-31 1992-07-14 Fujisawa Pharmaceutical Co., Ltd. Pyrrolidine derivatives
DE4121947A1 (de) * 1991-07-03 1993-01-07 Basf Ag 2-(3-(4-amidino-phenyl))-propionsaeurederivate, ihre herstellung und verwendung
US5731315A (en) * 1995-06-07 1998-03-24 Rhone-Poulenc Rorer Pharmaceuticals Inc. Substituted sulfonic acid n- (aminoiminomethyl)phenylalkyl!-azaheterocyclamide compounds
US5612353A (en) * 1995-06-07 1997-03-18 Rhone-Poulenc Rorer Pharmaceuticals Inc. Substituted (sulfinic acid, sulfonic acid, sulfonylamino or sulfinylamino) N-[(aminoiminomethyl)phenylalkyl]-azaheterocyclylamide compounds
CN1079396C (zh) * 1996-05-31 2002-02-20 C&C新药研究所 用作选择性凝血酶抑制剂的芳族脒衍生物
DE69718194T2 (de) * 1996-08-16 2003-10-16 Bristol-Myers Squibb Pharma Co., Wilmington Amidinophenyl-pyrrolidine, -pyrroline und -isoxazolidine und ihre derivate
IL130152A0 (en) * 1996-12-13 2000-06-01 Rhone Poulenc Rorer Pharma Sulfonic acid or sulfonylamino N-(heteroaralkyl)-azaheterocyclyamide compounds
US6281227B1 (en) * 1996-12-13 2001-08-28 Aventis Pharma Deutschland Gmbh Sulfonic acid sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds
IL123986A (en) * 1997-04-24 2011-10-31 Organon Nv Medicinal compounds

Similar Documents

Publication Publication Date Title
JP2002517393A5 (https=)
RU2225860C2 (ru) Ароматические гетероциклические соединения, обладающие активностью в отношении вич-интегразы
CN100577162C (zh) 用于联合治疗的取代的唑烷酮类化合物
RU2326881C2 (ru) Конденсированные производные азолпиримидина, обладающие свойствами ингибитора фосфатидилинозитол-3-киназы (pi3k)
US6281227B1 (en) Sulfonic acid sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds
RU2331647C2 (ru) Тиенопиримидиндионы и их применение в модулировании аутоиммунного заболевания
CA2319198A1 (en) Substituted oxoazaheterocyclyl factor xa inhibitors
JP2002523502A5 (https=)
HRP20130143T1 (hr) Derivati pirazolo piridina kao inhibitori nadph oksidaze
JP2008525502A5 (https=)
JP2004531484A5 (https=)
KR987000303A (ko) 신규한 퀴누클리딘 유도체 및 이의 의약 조성물(Novel quinuclidine derivatives and medicinal composition thereof)
HRP20150082T1 (hr) Derivati pirazolo piridina kao inhibitori nadph oksidaze
JP2002523511A5 (https=)
JP4504564B2 (ja) スルホン酸またはスルホニルアミノｎ−（ヘテロアラルキル）−アザヘテロシクリルアミド化合物
CA2600570A1 (en) Benzazole derivatives, compositions, and methods of use as .beta.-secretase inhibitors
CA2447779A1 (en) Dihydropyrrolo[1,2-a]indole and tetrahydropyrido[1,2-a]-indole derivatives as prostaglandin d2 receptor antagonists
ZA200301013B (en) Bicyclic pyrrolyl amides as glucogen phosphorylase inhibitors.
RU2003116649A (ru) Гетероциклилэфирзамещенные имидазохинолины
RU2002118622A (ru) Гетероциклические дигидропиримидиновые соединения
TW201339157A (zh) 化合物
RU2005136429A (ru) Производные азаспироалканов в качестве тнгибиторов металлопротеаз
HRP20120822T1 (hr) Supstituirani 4,5,6,7-tetrahidrotienopiridini kao kcnq2/3 modulatori za lijeäśenje boli, epilepsije i urinarne inkontinencije
RU2006136881A (ru) Фармацевтическая композиция, содержащая производное бензодиазепина и ингибитор белка слияния rsv
JP4223560B2 (ja) スルホン酸又はスルホニルアミノｎ−（ヘテロアラルキル）アザヘテロシクリルアミド化合物